July 7, 2020 / 4:43 AM / a month ago

BRIEF-Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals

July 7 (Reuters) - Caplin Point Laboratories Ltd:

* CAPLIN STERILES TO LICENSE 5 INJECTABLE ANDAS TO XELLIA

* APPROVAL FOR 4 PRODUCTS EXPECTED WITHIN NEXT 12-18 MONTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below